Get all premium features to the best stock analysis tool

Sold 272,777 Core Scientific shares; estimated trade value ~$4.8 million (based on quarterly average price) Sale equated to approximately 5.0% of the fund's reportable U.S. equity AUM as of December 31, 2025 Post-trade holding: 784,540 shares valued at $11.4 million Core Scientific remains a significant position, representing 11.9% of Galaxy Digital's 13F assets

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, today announced that it closed an additional $500 million commitment provided by JPMorgan Chase Bank, N.A. under the accordion feature of the Company's previously announced 364-day credit facility (the “Facility”). This brings total funded commitments under the Facility to $1.0 billion, including the previously announced $500.

Kintayl Capita sold 495,390 shares of Core Scientific in the fourth quarter; the estimated trade size was $8.64 million based on quarterly average prices. The quarter-end position value decreased by $9.14 million, reflecting both trading and stock price movements during the period.

Covalis (Gibraltar) Ltd initiated a new position in Core Scientific, buying 2,080,550 shares in the fourth quarter. The quarter-end position value increased by $30.29 million due to the new purchase.

AUSTIN, Texas & INDIANAPOLIS & SILVERSTONE, England--(BUSINESS WIRE)---- $CORZ--Core Scientific, Inc. (NASDAQ: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, and Cadillac Formula 1® Team have announced a multi-year global partnership, naming Core Scientific as the team's Official Data Center Partner. Core Scientific will play a central role in advising and shaping the team's data center infrastructure in its new U.S. headquarters, currently und.

AUSTIN, Texas--(BUSINESS WIRE)--Core Scientific, Inc. (Nasdaq: CORZ) (“Core Scientific” or the “Company”), a leader in digital infrastructure for high-density colocation, today announced that it completed the initial closing of a $500 million 364-day loan facility (the “Facility”) provided by Morgan Stanley. The Facility includes an accordion feature that provides the potential to increase total commitments by up to an additional $500 million, for total commitments of up to $1.0 billion, subjec.

Clearline Capital LP bought 3,436,127 shares of Core Scientific; estimated transaction value $59.91 million (based on average price for the quarter) Quarter-end position value increased $45.79 million, reflecting both trading and price appreciation Trade size represented 2.96% of 13F AUM Post-trade holding: 4,689,443 shares, valued at $68.28 million The position now accounts for 3.37% of reportable AUM, placing it outside the fund's top five holdings